Inspiritol®

Inspiritol®Inspiritol®Inspiritol®
  • Home
  • Inspiritol
  • About Us
  • Contact Us
  • More
    • Home
    • Inspiritol
    • About Us
    • Contact Us

Inspiritol®

Inspiritol®Inspiritol®Inspiritol®
  • Home
  • Inspiritol
  • About Us
  • Contact Us

Inspiritol

An inhaled multi-mechanism treatment for respiratory distress and post viral illnesses

comprised of broad spectrum anti-inflammatory, antiviral, antibacterial, ANTIFUNGAL compounds

comprised of broad spectrum anti-inflammatory, antiviral, antibacterial, ANTIFUNGAL compounds

comprised of broad spectrum anti-inflammatory, antiviral, antibacterial, ANTIFUNGAL compounds

comprised of broad spectrum anti-inflammatory, antiviral, antibacterial, ANTIFUNGAL compounds

comprised of broad spectrum anti-inflammatory, antiviral, antibacterial, ANTIFUNGAL compounds

Targets: COVID-19, Long-COVID, ME/CFS, COPD, Asthma and Influenza

comprised of broad spectrum anti-inflammatory, antiviral, antibacterial, ANTIFUNGAL compounds

Targets: COVID-19, Long-COVID, ME/CFS, COPD, Asthma and Influenza

treating ACUTE COVID-19, COPD and Asthma

Under Dr. Salerno's care 70 COPD, Asthma and COVID-19 patients varying in age from 12 to 86 years old were prescribed Inspiritol and reported substanative clinical improvements with no significant reported adverse events. 


At the core of Inspiritol are compounds that serve to reestablish the anti-oxidant oxidant balance in the lungs while reducing or eliminating inflammation associated with most acute respiratory distress. . 


Long Covid and me/cfs

Breaking the Long COVID and ME/CFS cycle of immune dysregulation with Inspiritol

Long-COVID and ME/CFS (Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome) result from aberrant responses to immunological triggers like an infection which results in a permanently dysregulated immune system as a result of over activation of certain T-Cells, their subsequent exhaustion and metabolic disruption . 


Dr. Salerno Collaboration with Dr. Liisa Selin


Recently, under an NIH funded research grant, Dr. Liisa Selin of UMass Chan Medical School, discovered similar immune system dysregulated responses in both Long-COVID and ME/CFS patients. These include  CD-8 T cell exhaustion, type II interferon exhaustion and evidence of difficulty controlling persistent viral pathogens. 

With the same biomarker analyses, they reported the treatment of Long-COVID and ME/CFS patients using Inspiritol resulted in modulation of their immune system response towards a more normal profile in addition to sustained symptomatic relief.

Dr. Selin discussing Inspiritol as a Treatement

Dr. Selin Interview

Inspiritol® inc., 

Copyright © 2023

 inspiritol.com - All Rights Reserved.